Suzhou Huajian Ruida Pharmaceutical Technology

Suzhou Huajian Ruida Pharmaceutical Technology is a high-tech pharmaceutical company based in Suzhou Industrial Park, China. Founded in 2015, the company focuses on the research, development, and industrialization of high-end generic drugs under the Marketing Authorization Holder (MAH) system. It provides comprehensive pharmaceutical CMC (Chemistry, Manufacturing, and Controls) services, including formulation screening, process development, quality research, and consistency evaluations. The company's product portfolio spans multiple therapeutic areas such as respiratory, cardiovascular, and metabolic diseases, with marketed products including Fudosteine Oral Solution and Ezetimibe Tablets.